Serotonin	serotonin	S_chemicals	B_disease
syndrome	syndrome	O	S_disease
from	from	O	O
venlafaxine-tranylcypromine	venlafaxine-tranylcypromine	O	O
interaction	interaction	O	O
.	.	O	O

Excessive	excessive	O	O
stimulation	stimulation	O	O
of	of	O	O
serotonin	serotonin	S_chemicals	O
5HT1A	5ht1a	O	O
receptors	receptors	O	O
causes	causes	O	O
a	a	O	O
syndrome	syndrome	O	S_disease
of	of	O	O
serotonin	serotonin	S_chemicals	O
excess	excess	O	O
that	that	O	O
consists	consists	O	O
of	of	O	O
shivering	shivering	O	O
,	,	O	O
muscle	muscle	O	B_disease
rigidity	rigidity	O	I_disease
,	,	O	O
salivation	salivation	O	O
,	,	O	O
confusion	confusion	O	S_disease
,	,	O	O
agitation	agitation	O	O
and	and	O	O
hyperthermia	hyperthermia	O	S_disease
.	.	O	O

The	the	O	O
most	most	O	O
common	common	O	O
cause	cause	O	O
of	of	O	O
this	this	O	O
syndrome	syndrome	O	S_disease
is	is	O	O
an	an	O	O
interaction	interaction	O	O
between	between	O	O
a	a	O	O
monoamine	monoamine	B_chemicals	O
oxidase	oxidase	S_chemicals	O
inhibitor	inhibitor	I_chemicals	O
(	(	O	O
MAOI	maoi	O	O
)	)	O	O
and	and	O	O
a	a	O	O
specific	specific	O	O
serotonin	serotonin	B_chemicals	O
reuptake	reuptake	B_chemicals	O
inhibitor	inhibitor	I_chemicals	O
.	.	O	O

Venlafaxine	venlafaxine	S_chemicals	O
is	is	O	O
a	a	O	O
new	new	O	O
antidepressant	antidepressant	S_chemicals	O
agent	agent	O	O
that	that	O	O
inhibits	inhibits	O	O
the	the	O	O
reuptake	reuptake	O	O
of	of	O	O
serotonin	serotonin	S_chemicals	O
and	and	O	O
norepinephrine	norepinephrine	S_chemicals	O
.	.	O	O

We	we	O	O
report	report	O	O
a	a	O	O
venlafaxine-MAOI	venlafaxine-maoi	O	O
interaction	interaction	O	O
that	that	O	O
resulted	resulted	O	O
in	in	O	O
the	the	O	O
serotonin	serotonin	S_chemicals	B_disease
syndrome	syndrome	O	S_disease
in	in	O	O
a	a	O	O
23-y-old	23-y-old	O	O
male	male	O	O
who	who	O	O
was	was	O	O
taking	taking	O	O
tranylcypromine	tranylcypromine	S_chemicals	O
for	for	O	O
depression	depression	O	O
.	.	O	O

He	he	O	O
had	had	O	O
been	been	O	O
well	well	O	O
until	until	O	O
the	the	O	O
morning	morning	O	O
of	of	O	O
presentation	presentation	O	O
when	when	O	O
he	he	O	O
took	took	O	O
1/2	1/2	O	O
tab	tab	O	O
of	of	O	O
venlafaxine	venlafaxine	S_chemicals	O
.	.	O	O

Within	within	O	O
2	2	O	O
h	h	O	O
he	he	O	O
became	became	O	O
confused	confused	O	O
with	with	O	O
jerking	jerking	O	O
movements	movements	O	O
of	of	O	O
his	his	S_chemicals	O
extremities	extremities	O	O
,	,	O	O
tremors	tremors	O	S_disease
and	and	O	O
rigidity	rigidity	O	O
.	.	O	O

He	he	O	O
was	was	O	O
brought	brought	O	O
directly	directly	O	O
to	to	O	O
a	a	O	O
hospital	hospital	O	O
where	where	O	O
he	he	O	O
was	was	O	O
found	found	O	O
to	to	O	O
be	be	O	O
agitated	agitated	O	O
and	and	O	O
confused	confused	O	O
with	with	O	O
shivering	shivering	O	O
,	,	O	O
myoclonic	myoclonic	O	B_disease
jerks	jerks	O	I_disease
,	,	O	O
rigidity	rigidity	O	O
,	,	O	O
salivation	salivation	O	O
and	and	O	O
diaphoresis	diaphoresis	O	O
.	.	O	O

His	his	S_chemicals	O
pupils	pupils	O	O
were	were	O	O
7	7	O	O
mm	mm	O	O
and	and	O	O
sluggishly	sluggishly	O	O
reactive	reactive	O	O
to	to	O	O
light	light	O	O
.	.	O	O

Vital	vital	O	O
signs	signs	O	O
were	were	O	O
:	:	O	O
blood	blood	O	B_disease
pressure	pressure	O	I_disease
120/67	120/67	O	O
mm	mm	O	O
Hg	hg	O	O
,	,	O	O
heart	heart	O	O
rate	rate	O	O
127/min	127/min	O	O
,	,	O	O
respiratory	respiratory	O	O
rate	rate	O	O
28/min	28/min	O	O
,	,	O	O
and	and	O	O
temperature	temperature	O	O
97	97	O	O
F.	f.	O	O
After	after	O	O
180	180	O	O
mg	mg	O	O
of	of	O	O
diazepam	diazepam	S_chemicals	O
i.v	i.v	O	O
.	.	O	O
he	he	O	O
remained	remained	O	O
tremulous	tremulous	O	O
with	with	O	O
muscle	muscle	O	B_disease
rigidity	rigidity	O	I_disease
and	and	O	O
clenched	clenched	O	O
jaws	jaws	O	O
.	.	O	O

He	he	O	O
was	was	O	O
intubated	intubated	O	O
for	for	O	O
airway	airway	O	O
protection	protection	O	O
and	and	O	O
because	because	O	O
of	of	O	O
hypoventilation	hypoventilation	O	S_disease
,	,	O	O
and	and	O	O
was	was	O	O
paralyzed	paralyzed	O	O
to	to	O	O
control	control	O	O
muscle	muscle	O	B_disease
rigidity	rigidity	O	I_disease
.	.	O	O

His	his	S_chemicals	O
subsequent	subsequent	O	O
course	course	O	O
was	was	O	O
remarkable	remarkable	O	O
for	for	O	O
non-immune	non-immune	O	S_disease
thrombocytopenia	thrombocytopenia	O	S_disease
which	which	O	O
resolved	resolved	O	O
.	.	O	O

The	the	O	O
patient	patient	O	O
's	's	O	O
maximal	maximal	O	O
temperature	temperature	O	O
was	was	O	O
101.2	101.2	O	O
F	f	O	O
and	and	O	O
his	his	S_chemicals	O
CPK	cpk	O	O
remained	remained	O	O
<	<	O	O
500	500	O	O
units/L	units/l	O	O
with	with	O	O
no	no	O	O
other	other	O	O
evidence	evidence	O	O
of	of	O	O
rhabdomyolysis	rhabdomyolysis	O	S_disease
.	.	O	O

His	his	S_chemicals	O
mental	mental	O	O
status	status	O	O
normalized	normalized	O	O
and	and	O	O
he	he	O	O
was	was	O	O
transferred	transferred	O	O
to	to	O	O
a	a	O	O
psychiatry	psychiatry	O	O
ward	ward	O	O
.	.	O	O

This	this	O	O
patient	patient	O	O
survived	survived	O	O
without	without	O	O
sequelae	sequelae	O	O
due	due	O	O
to	to	O	O
the	the	O	O
aggressive	aggressive	O	O
sedation	sedation	O	O
and	and	O	O
neuromuscular	neuromuscular	O	O
paralysis	paralysis	O	S_disease
.	.	O	O

